期刊文献+
共找到482篇文章
< 1 2 25 >
每页显示 20 50 100
Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma 被引量:1
1
作者 Jun-Ling Yang Jie Yang +3 位作者 Rong-Fei Fang Wen-Li Sai Deng-Fu Yao Min Yao 《World Journal of Hepatology》 2024年第12期1480-1492,共13页
BACKGROUND Angiopoietin-2(Ang-2)level is related to hepatocellular carcinoma(HCC)pro-gression.However,the dynamic expression and regulatory mechanism of Ang-2 remain unclear.AIM To investigate Ang-2 levels in chronic ... BACKGROUND Angiopoietin-2(Ang-2)level is related to hepatocellular carcinoma(HCC)pro-gression.However,the dynamic expression and regulatory mechanism of Ang-2 remain unclear.AIM To investigate Ang-2 levels in chronic liver diseases and validate early monitoring value with a dynamic model in hepatocarcinogenesis.METHODS Sprague-Dawley rats in hepatocarcinogenesis were induced with diet 2-fluo-renylacet-amide,and grouped based on liver histopathology by hematoxylin and eosin staining.Differently expressed genes or Ang-2 mRNA in livers were ana-lyzed by whole-genome microarray.Ang-2 levels in chronic liver diseases were detected by an enzyme-linked immunosorbent assay.RESULTS Clinical observation reveled that the circulating levels of Ang-2 and hypoxia-inducible factor-1α(HIF-1α)in patients with chronic liver diseases were progressively increased from benign to HCC(P<0.001).Dynamic model va-lidated that the up-regulated Ang-2 in liver and blood was positively correlated with HIF-1αin hepatocarcino-genesis(P<0.001).Mechanistically,Ang-2 was regulated by HIF-1α.When specific HIF-1α-microRNAs transfected into HCC cells,the cell proliferation significantly inhibited,HIF-1αand Ang-2 down-regulated,and also affected epithelial-mesenchymal transition via increasing E-cadherin to block cell invasion or migration with reducing of snail,twist and vimentin.CONCLUSION Hypoxia-induced Ang-2 up-regulating expression might serve as a sensitive early monitoring biomarker for hepatocarcinogenesis or HCC metastasis. 展开更多
关键词 angiopoietin-2 Hypoxia-inducible factor-1α HEPATOCARCINOGENESIS Dynamic model Metastasis
下载PDF
Recurrent stroke admissions with vs without COVID-19 and associated in-hospital mortality: A United States nationwide analysis, 2020 被引量:1
2
作者 Rupak Desai Sai Priyanka Mellacheruvu +7 位作者 Sai Anusha Akella Adil Sarvar Mohammed Mushfequa Hussain Abdul Aziz Mohammed Pakhal Saketha Praveena Sunkara Jyotsna Gummadi Paritharsh Ghantasala 《World Journal of Virology》 2024年第3期98-106,共9页
BACKGROUND Coronavirus disease 2019(COVID-19)has been shown to increase the risk of stroke.However,the prevalence and risk of recurrent stroke in COVID-19 patients with prior stroke/transient ischemic attack(TIA),as w... BACKGROUND Coronavirus disease 2019(COVID-19)has been shown to increase the risk of stroke.However,the prevalence and risk of recurrent stroke in COVID-19 patients with prior stroke/transient ischemic attack(TIA),as well as its impact on mor-tality,are not established.AIM To evaluate the impact of COVID-19 on in-hospital mortality,length of stay,and healthcare costs in patients with recurrent strokes.METHODS We identified admissions of recurrent stroke(current acute ischemic stroke admissions with at least one prior TIA or stroke)in patients with and without COVID-19 using ICD-10-CM codes using the National Inpatient Sample(2020).We analyzed the impact of COVID-19 on mortality following recurrent stroke admissions by subgroups.RESULTS Of 97455 admissions with recurrent stroke,2140(2.2%)belonged to the COVID-19-positive group.The COVID-19-positive group had a higher prevalence of diabetes and chronic kidney disease vs the COVID-19 negative group(P<0.001).Among the subgroups,patients aged>65 years,patients aged 45–64 years,Asians,Hispanics,whites,and blacks in the COVID-19 positive group had higher rates of all-cause mortality than the COVID-19 negative group(P<0.01).Higher odds of in-hospital mortality were seen in the group aged 45-64(OR:8.40,95%CI:4.18-16.91)vs the group aged>65(OR:7.04,95%CI:5.24-9.44),males(OR:7.82,95%CI:5.38-11.35)compared to females(OR:6.15,95%CI:4.12-9.18),and in Hispanics(OR:15.47,95%CI:7.61-31.44)and Asians/Pacific Islanders(OR:14.93,95%CI:7.22-30.87)compared to blacks(OR:5.73,95%CI:3.08-10.68),and whites(OR:5.54,95%CI:3.79-8.09).CONCLUSION The study highlights the increased risk of all-cause in-hospital mortality in recurrent stroke patients with COVID-19,with a more pronounced increase in middle-aged patients,males,Hispanics,or Asians. 展开更多
关键词 COVID-19 SARS-CoV-2 recurrent stroke MORTALITY HOSPITALIZATION COMORBIDITIES Acute ischemic stroke
下载PDF
Repeat recurrence of takotsubo cardiomyopathy related to inhaled beta-2-adrenoceptor agonists 被引量:2
3
作者 Ivan Mendoza Gian M Novaro 《World Journal of Cardiology》 CAS 2012年第6期211-213,共3页
Takotsubo cardiomyopathy (also referred to as transient apical ballooning syndrome, broken heart syndrome or stress cardiomyopathy) is an increasingly recognized entity in the western world typically characterized by ... Takotsubo cardiomyopathy (also referred to as transient apical ballooning syndrome, broken heart syndrome or stress cardiomyopathy) is an increasingly recognized entity in the western world typically characterized by reversible left ventricular dysfunction that develops in the setting of acute severe emotional or physical stress. Increased catecholamine levels have been proposed to play a central role in the pathogenesis of the disease, although the specific pathophysiology of this condition remains elusive at the present moment. In recent times, there have been reports of takotsubo cardiomyopathy (TC) following medical interventions such as invasive or surgical procedures or specific medical regimens. In the current report, we present a patient with multiple recurrences of TC triggered by the same medical therapeutic intervention; in our particular case, repetitive exposure to inhaled beta-2-adrenoceptor agonist. 展开更多
关键词 TAKOTSUBO Beta-2-adrenoreceptor agonist recurrence Ventricular dysfunction Heart failure
下载PDF
Populational change of CD4^(+)CD25^(+)Treg cells is responsible for the synergistic effect of the combination of RAMP2 with baicalin in treating recurrent spontaneous abortion mouse models
4
作者 Cong Chen Zhuo-Lan Li +2 位作者 Jing-Tian Guo Wen-Yao Xue Wei Guo 《Traditional Medicine Research》 2024年第8期59-66,共8页
Background: The absence of a safe and effective therapy for recurrent spontaneous abortion due to a maternofetal failure in immunological tolerance remains an intractable clinical obstacle for surgeons. Recently, trad... Background: The absence of a safe and effective therapy for recurrent spontaneous abortion due to a maternofetal failure in immunological tolerance remains an intractable clinical obstacle for surgeons. Recently, traditional Chinese medicine has become a feasible alternative for certain diseases, including recurrent spontaneous abortion. However, because of the complex composition of the traditional Chinese medicine formula, its action mechanism remains unclear. Methods: We selected two isolated active ingredients (RAMP and baicalin) from the traditional Chinese medicine formula and used an abortion-prone CBA/J × DBA/2 model to simulate human RSA and compared the changes in fetal resorption rate, Treg cell percentage, and relevant cytokines before and after combination therapy. In addition, The mechanisms were preliminarily discussed using in vitro differentiation models. Results: In CBA/J × DBA/2 abortion-prone mice, the combination therapy resulted in a lower embryo resorption rate compared to that obtained with individual delivery of either RAMP or baicalin, thereby playing an embryo-protective role through the increase in Treg cells for the maintenance of maternal-fetal immune tolerance. In in vitro primary cell differentiation experiments, the concentration of Treg cells significantly increased from 11% to 17.9% after the combination therapy compared to that of the single administration group. Conclusion: the synergistic effects of RAMP and baicalin were responsible for Treg differentiation. The present study provides a solid basis for improving the applicability of traditional Chinese herbs in the treatment of recurrent spontaneous abortion. 展开更多
关键词 recurrent spontaneous abortion Atractylodes macrocephala Koidz. Scutellaria baicalensis Georgi CBA/J×DBA/2 regulatory T cells
下载PDF
生存素、人类表皮生长因子受体2、巨囊性病液体蛋白15、Yes相关蛋白表达对乳腺癌患者术后复发转移的预测价值
5
作者 卜烨 张晨洁 《陕西医学杂志》 CAS 2025年第1期127-131,共5页
目的:研究生存素(Survivin)、人类表皮生长因子受体2(HER-2)、巨囊性病液体蛋白15(GCDFP15)、Yes相关蛋白(YAP)表达对乳腺癌患者术后复发转移的预测价值。方法:收集156例经乳腺癌改良根治术治疗的乳腺癌患者乳腺癌病理组织及癌旁正常组... 目的:研究生存素(Survivin)、人类表皮生长因子受体2(HER-2)、巨囊性病液体蛋白15(GCDFP15)、Yes相关蛋白(YAP)表达对乳腺癌患者术后复发转移的预测价值。方法:收集156例经乳腺癌改良根治术治疗的乳腺癌患者乳腺癌病理组织及癌旁正常组织,比较乳腺癌患者癌组织和癌旁正常组织Survivin、HER-2、GCDFP15、YAP蛋白表达情况;所有患者术后均随访2年,根据患者术后随访期间复发转移情况将其分为Ⅰ组(51例)和Ⅱ组(105例),统计两组一般资料,比较两组癌组织Survivin、HER-2、GCDFP15、YAP蛋白表达情况,分析乳腺癌患者术后2年内复发转移的影响因素及癌组织Survivin、HER-2、GCDFP15、YAP蛋白单一及联合检测对乳腺癌患者术后2年复发转移的预测价值。结果:癌组织Survivin、HER-2、GCDFP15阳性表达率高于正常组织,YAP阳性表达率低于正常组织(均P<0.05)。Ⅰ组低分化、临床分期Ⅲ期患者占比高于Ⅱ组(均P<0.05)。Ⅰ组癌组织Survivin、HER-2、GCDFP15阳性表达率高于Ⅱ组,YAP阳性表达率低于Ⅱ组(均P<0.05)。分化程度为低分化、临床分期Ⅲ期及Survivin、HER-2、GCDFP15蛋白阳性表达均为乳腺癌患者术后2年内复发转移的独立危险因素(OR=2.092、1.992、2.059、1.815、1.857,均P<0.05);YAP蛋白阳性表达为乳腺癌患者术后2年内复发转移的保护因素(OR=0.489,P<0.05)。癌组织Survivin、HER-2、GCDFP15、YAP蛋白联合预测乳腺癌患者术后2年复发转移的曲线下面积(AUC)值高于四者单独检测(均P<0.05)。结论:乳腺癌的发生与Survivin、HER-2、GCDFP15、YAP蛋白表达情况有关,且患者术后2年复发转移的发生与其分化程度、临床分期及Survivin、HER-2、GCDFP15、YAP蛋白表达情况有关,同时Survivin、HER-2、GCDFP15、YAP蛋白联合可有效提高对乳腺癌患者术后2年复发转移的预测价值。 展开更多
关键词 乳腺癌 生存素 人类表皮生长因子受体2 巨囊性病液体蛋白15 Yes相关蛋白 复发 转移 预测价值
下载PDF
Expression of Cyclooxygenase-2 and Transforming Growth Factor-Beta 1 in Patients with the Early Recurrence of Hepatocellular Carcinoma Following Hepatectomy
6
作者 Takayuki Nakase Masaki Ueno +2 位作者 Kazuhisa Uchiyama Nariaki Matsuura Hiroki Yamaue 《Surgical Science》 2012年第6期322-331,共10页
Background: Cyclooxygenase-2 (COX-2) and transforming growth factor-beta1 (TGF-β1) are modulated in variety cancers including Hepatocellular carcinoma (HCC). However, there is a paucity of data concerning their role ... Background: Cyclooxygenase-2 (COX-2) and transforming growth factor-beta1 (TGF-β1) are modulated in variety cancers including Hepatocellular carcinoma (HCC). However, there is a paucity of data concerning their role in the pathologic process of recurrence of HCC following hepatectomy. We herein assessed the role of the hepatic expression of COX-2 and TGF-β as predictors for patients with early recurrence within 2 years of HCC diagnosis. Methods: Sixty patients with HCC who underwent curative hepatectomy between 2000 and 2003 were entered in the present study. The immunoreactivity and distribution patterns of COX-2 and TGF-β1 were examined in both the HCC and the adjacent nonHCC tissues of the liver. Risk factors of tumor recurrence within 2 years, including COX-2 and TGF-β1 expression, were investigated by univariate and multivariate analyses. Results: Among 60 patients, 31 patients had early recurrences within 2 years and 14 patients recurred after 2 years following surgery. Patients with low COX-2 expression in the HCC tissues and adjacent nonHCC tissues had favorable disease-free survival (p = 0.002 and p β1 expression in the nonHCC tissues had also longer disease-free survival (p = 0.045). Based on the expression patterns of COX-2 and TGF-β1, patients with low COX-2 and positive TGF-β1 expression in the nonHCC tissues had favorable overall and disease-free survival (p β1 signaling in nontumor tissues suggested high risk of recurrence and poor survival to the HCC patients following hepatectomy. 展开更多
关键词 CYCLOOXYGENASE-2 TRANSFORMING Growth Factor-Beta1 HEPATOCELLULAR Carcinoma Early recurrence HEPATECTOMY
下载PDF
血清网膜素-1和血管生成素样蛋白2水平与心房颤动病人射频消融术后复发的相关性研究
7
作者 范彩逢 郭玉冰 齐玉婕 《安徽医药》 CAS 2025年第1期100-104,共5页
目的探究血清网膜素-1(Omentin-1)和血管生成素样蛋白2(ANGPTL2)水平与心房颤动(AF)病人射频消融术后复发的相关性。方法选取2021年1月至2022年1月在郑州大学附属洛阳中心医院实施射频消融术治疗的125例AF病人,依据随访结果分为两组:未... 目的探究血清网膜素-1(Omentin-1)和血管生成素样蛋白2(ANGPTL2)水平与心房颤动(AF)病人射频消融术后复发的相关性。方法选取2021年1月至2022年1月在郑州大学附属洛阳中心医院实施射频消融术治疗的125例AF病人,依据随访结果分为两组:未复发组(n=93)、复发组(n=32);血清Omentin-1、ANGPTL2、白细胞介素(IL)-6、IL-8、肿瘤坏死因子α(TNF-α)水平行酶联免疫吸附测定(ELISA);AF病人术后血清Omentin-1、ANGPTL2水平与各指标相关性采用Pearson分析;多因素logistic分析AF病人术后复发影响因素;采用受试者操作特征曲线(ROC曲线)评价血清Omentin-1、ANGPTL2水平在预测AF病人术后复发中的价值。结果复发组血清IL-6[(3.56±0.73)ng/L]、IL-8[(8.26±2.58)ng/L]、TNF-α[(7.34±2.19)ng/L]、左心房内径(LAD)水平[(37.24±5.23)mm]较未复发组[(1.41±0.26)ng/L、(3.49±1.04)ng/L、(2.67±0.63)ng/L、(31.44±4.16)mm]均显著升高,LVEF水平较未复发组显著降低(P<0.05);与未复发组比较,复发组血清Omentin-1水平显著降低,复发组血清ANGPTL2上水平显著升高(P<0.05);Pearson分析显示,AF病人术前血清Omentin-1水平与炎症因子IL-6、IL-8、TNF-α及LAD均呈负相关,与LVEF呈正相关(P<0.05);血清ANGPTL2水平与炎症因子IL-6、IL-8、TNF-α及LAD水平均呈正相关,与LVEF呈负相关(P<0.05),且Omentin-1、ANGPTL2水平呈负相关;多因素logistic分析显示,高水平Omentin-1为AF病人术后复发的独立保护因素,高水平ANGPTL2、IL-6、IL-8均为AF病人术后复发的独立危险因素(P<0.05);ROC曲线分析显示,血清Omentin-1、ANGPTL2水平预测AF病人术后复发的曲线下面积(AUC)分别为0.88、0.84,两者联合预测的AUC为0.94,效能均优于两者单独预测(Z=1.93、2.10,P<0.05)。结论AF病人术后血清Omentin-1水平显著降低,血清ANGPTL2水平显著升高,与术后复发相关,且两者联合对预测AF术后复发具有一定价值。 展开更多
关键词 心房颤动 射频消融术 网膜素-1 血管生成素样蛋白2 复发
下载PDF
口腔鳞癌组织中Angiopoietin-1、Angiopoietin-2的表达及临床意义 被引量:8
8
作者 李超 冯红超 +1 位作者 陈建超 宋宇峰 《癌症》 SCIE CAS CSCD 北大核心 2005年第11期1388-1393,共6页
背景与目的:近来研究表明Angiopoietin-1、Angiopoietin-2(Ang-1、Ang-2)是极有潜力的血管生长因子,它们与其它血管生长因子之间的局部平衡关系决定了血管是进展、稳定还是衰退。本文探讨Ang-1及Ang-2在口腔鳞癌中的表达及其与临床病理... 背景与目的:近来研究表明Angiopoietin-1、Angiopoietin-2(Ang-1、Ang-2)是极有潜力的血管生长因子,它们与其它血管生长因子之间的局部平衡关系决定了血管是进展、稳定还是衰退。本文探讨Ang-1及Ang-2在口腔鳞癌中的表达及其与临床病理学特征和微血管密度(microvesseldensity,MVD)、血管成熟指数(vesselmaturationindex,VMI)之间的关系,并评估Ang-1及Ang-2的联合表达在肿瘤血管生成及成熟中的作用。方法:用常规免疫组织化学的方法检测41例口腔鳞癌及30例癌旁正常组织和10例正常口腔粘膜中的Ang-1及Ang-2的表达;通过双标免疫组织化学法同时检测CD34和α-平滑肌肌动蛋白,评估MVD及VMI。结果:口腔鳞癌组织与癌旁正常组织及正常口腔粘膜相比,Ang-2的表达显著增加(51.22%vs.26.67%,0%),而Ang-1的表达显著降低(41.46%vs.90.00%,90.00%),P值均<0.05;在癌旁正常组织与正常口腔粘膜之间,二者的表达没有显著性差异(P均>0.05)。对临床病理因素的分析发现,在高分化肿瘤中Ang-1的阳性率显著高于中分化肿瘤(56.00%vs.18.75%,P<0.05);而Ang-2的阳性率在有淋巴结转移的肿瘤显著高于无淋巴结转移肿瘤(84.62%vs.35.71%,P<0.01)。Ang-1和Ang-2的表达与肿瘤的血管生成及血管成熟密切相关(P值均<0.05)。联合Ang-1和Ang-2的表达发现,Ang-1与Ang-2相互拮抗共同调节肿瘤的血管成熟。结论:口腔鳞癌中Ang-1表达降低及Ang-2表达增高与肿瘤血管的生成及成熟密切相关。 展开更多
关键词 angiopoietin-1 angiopoietin-2 口腔肿瘤 鳞状细胞 血管生成 血管成熟
下载PDF
人横纹肌肉瘤拟态血管生成能力及与angiopoietin-2、laminin5γ2关系的研究 被引量:4
9
作者 杨爱军 穆继英 +2 位作者 刘伟 王晨昱 李敏 《临床与实验病理学杂志》 CAS CSCD 北大核心 2008年第6期721-724,共4页
目的观察人横纹肌肉瘤(rhabdomyosarcoma,RMS)在体内、外拟态血管的形成能力;探讨angiopoietin-2(Ang2)和laminin5γ2(LN-5γ2)在肿瘤血管生成拟态(vasculogenic mimicry,VM)发生中的作用。方法应用三维培养技术、抗体阻断技术等观察人... 目的观察人横纹肌肉瘤(rhabdomyosarcoma,RMS)在体内、外拟态血管的形成能力;探讨angiopoietin-2(Ang2)和laminin5γ2(LN-5γ2)在肿瘤血管生成拟态(vasculogenic mimicry,VM)发生中的作用。方法应用三维培养技术、抗体阻断技术等观察人胚胎性横纹肌肉瘤细胞株RD细胞及小鼠黑色素瘤细胞株B16细胞在体外培养时拟态血管的形成能力并检测CD31、Ang2及LN-5γ2在VM形成过程中的表达改变。收集13例人横纹肌肉瘤石蜡包埋组织连续切片,观察拟态血管的存在,并应用免疫组织化学方法检测CD31、Ang2与LN-5γ2的表达。结果人胚胎性横纹肌肉瘤细胞RD三维培养后能够降解基质,形成空腔、裂隙样结构,在此过程中,LN-5γ2逐渐开始表达,而Ang2与CD31的表达出现不均衡增强,在血管腔样结构的管壁上Ang2、CD31与LN-5γ2均表达阳性。应用anti-Ang2及anti-LN-5γ2均能够抑制瘤细胞网环样结构的形成;anti-Ang2能降低LN-5γ2的表达强度。13例横纹肌肉瘤中VM形成率达69.2%。结论人横纹肌肉瘤在体内外都能够形成拟态血管。Ang2可能通过上调LN-5γ2的表达促进瘤细胞拟态血管的形成。 展开更多
关键词 软组织肿瘤 血管生成拟态 横纹肌肉瘤 三维培养 angiopoietin-2 laminin5γ2
下载PDF
Expression of Angiopoietin-2 and Vascular Endothelial Growth Factor in Oral Squamous Cell Carcinoma and Its Significance 被引量:3
10
作者 李超 冯红超 宋宇峰 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第4期232-237,共6页
Objective: To investigate the expression of angiopoietin-2 (Ang-2) and vascular endothelialcell growth factor (VEGF) in oral squamous cell carcinoma (OSCC) and their correlations with clinicopathologic paramete... Objective: To investigate the expression of angiopoietin-2 (Ang-2) and vascular endothelialcell growth factor (VEGF) in oral squamous cell carcinoma (OSCC) and their correlations with clinicopathologic parameters, angiogenesis and vessel maturation of OSCC. Methods: The expression of Ang-2 and VEGF was detected in 41 speciments of human OSCC, 30 adjacent noncancerous oral tissues and 10 specimens of normal oral mucosa by conventional immumohistochemistry. Microvessel density (MVD) and vessel maturation index (VMI) were also assessed by double-labelling immumohistochemistry staining against CD34, a marker of pan-endothelial cells, and that against alpha-smooth muscle actin (α-SMA), a marker of mural cells (pericytes/smooth muscle cells). Results: The positive expression rate of Ang-2 and VEGF in 41 OSCC tissues was 51.22% and 63.42%, respectively. The expression of Ang-2 and VEGF was significantly higher in OSCC than in adjacent noncancerous oral tissues (all P〈0.05) and normal oral mucosa (all P〈0.05). In the clinicopathologic parameters, the Ang-2 expression was closely correlated with tumor lymph node metastasis (P〈0.01) and the VEGF expression was correlated with tumor differentiated degree (P〈0.05), but there was no significant correlation among the Ang-2 and VEGF expression and patients' sex, age and TNM stages (all P〉0.05). The MVD of OSCC positive for both Ang-2 and VEGF was significantly higher than that of OSCC negative for both Ang-2 and VEGF (P〈0.05). The VMI of OSCC positive for Ang-2 was significantly lower than that of OSCC negative for Ang-2 (P〈0.05). When Ang-2 expression was combined with the staus of VEGF expression, MVD of OSCC positive for both Ang-2 and VEGF was the highest (51.08±2.99) as compared with that of other status in patient with OSCC (all P〈0.05). Conclusion: The overexpression of Ang-2 and VEGF may play a crucial role in the development of OSCC. They are closely associated with angiogenesis and vessel maturation of tumor. 展开更多
关键词 angiopoietin-2 VEGF ANGIOGENESIS mouth neoplasms microvessel density vessel maturation
下载PDF
原发性肝癌Angiopoietin-2的表达与血管生成的关系 被引量:1
11
作者 孙海东 朱理玮 张东昌 《武警医学院学报》 CAS 2006年第4期305-307,共3页
【目的】观察Angiopoietin-2在原发性肝癌中的表达情况及其与微血管密度(Micro-vessel density,MVD)的关系。【方法】免疫组化S-P法检测30例原发性肝癌组织的表达情况,并应用免疫组化S-P法检测An-giopoietin-2、CD34的表达,以CD34标记... 【目的】观察Angiopoietin-2在原发性肝癌中的表达情况及其与微血管密度(Micro-vessel density,MVD)的关系。【方法】免疫组化S-P法检测30例原发性肝癌组织的表达情况,并应用免疫组化S-P法检测An-giopoietin-2、CD34的表达,以CD34标记肿瘤微血管,并在显微镜下计数微血管密度(MVD)。【结果】癌旁组织中无Angiopoietin-2表达,Angiopoietin-2在原发性肝癌表达阳性率为67%,其表达与原发性肝癌恶性程度、淋巴结转移相关(P<0.01),而与侵犯深度组织学类型无关(P>0.05);CD-34的表达与原发性肝癌的侵食性相关,而与有无包膜无关。Angiopoietin-2的表达与MVD呈正相关,Angiopoietin-2阳性表达组中MVD明显高于Angiopoietin-2阴性表达组(P<0.01)。【结论】Angiopoietin-2在原发性肝癌中高表达,在原发性肝癌的发生、发展中起重要的作用,与原发性肝癌的分化程度、侵袭性高低、血管生成有关。 展开更多
关键词 原发性肝癌 angiopoietin-2 血管生成
下载PDF
Angiopoietin-2和Tie-2在人乳腺癌组织中的表达及临床意义
12
作者 付传恒 户庄 +3 位作者 常亮 周振宇 马明德 傅侃达 《中国医学创新》 CAS 2016年第32期22-24,共3页
目的:探讨Angiopoietin-2和Tie-2在人乳腺癌组织中的表达及其临床意义。方法:应用免疫组织化学法检测乳腺癌组织和正常乳腺组织中Angiopoietin-2和Tie-2的表达情况,并分析其与临床病理学特征及预后间的相关性。结果:Angiopoietin-2在乳... 目的:探讨Angiopoietin-2和Tie-2在人乳腺癌组织中的表达及其临床意义。方法:应用免疫组织化学法检测乳腺癌组织和正常乳腺组织中Angiopoietin-2和Tie-2的表达情况,并分析其与临床病理学特征及预后间的相关性。结果:Angiopoietin-2在乳腺癌和正常乳腺组织中的阳性表达率分别为80.99%(98/121)、10.53%(4/38),Tie-2在乳腺癌和正常乳腺组织中的阳性表达率分别为75.21%(91/121)、15.79%(6/38),乳腺癌中Angiopoietin-2和Tie-2的阳性表达率均显著高于正常乳腺组织(P<0.05)。Angiopoietin-2、Tie-2的表达与病理分期、腋窝淋巴结转移及预后相关(P<0.05)。结论:Angiopoietin-2和Tie-2在乳腺癌组织中呈高表达,其可能成为预测乳腺癌发生发展及预后的生物标志物。 展开更多
关键词 乳腺癌 angiopoietin-2 TIE-2 预后
下载PDF
P130CAS对食管癌细胞ECA109中Angiopoietin-2表达及其生物学行为的影响
13
作者 唐绪容 黄伟 +2 位作者 屈虹 马洪飚 罗锋 《临床与实验病理学杂志》 CAS CSCD 北大核心 2018年第8期840-844,共5页
目的探讨抑制P130CAS(P130 Crk-associated substrate)基因对食管癌细胞ECA109中Angiopoietin-2表达和生物学行为的影响。方法构建P130CAS基因siRNA慢病毒载体,感染ECA109细胞,荧光显微镜观察感染效率,应用RT-PCR和Western blot法检测... 目的探讨抑制P130CAS(P130 Crk-associated substrate)基因对食管癌细胞ECA109中Angiopoietin-2表达和生物学行为的影响。方法构建P130CAS基因siRNA慢病毒载体,感染ECA109细胞,荧光显微镜观察感染效率,应用RT-PCR和Western blot法检测其干扰效率。应用CCK-8法、划痕实验、Transwell实验、Western blot法检测抑制P130CAS基因表达对ECA109细胞增殖、迁移、侵袭能力和对Angiopoietin-2蛋白表达的影响。结果成功构建PLVT716 siRNA慢病毒载体,ECA109细胞P130CAS mRNA和蛋白表达明显下调(P<0.05),并建立稳定细胞株;抑制P130CAS基因表达导致ECA109细胞增殖、迁移和侵袭能力显著减弱(P<0.05),同时Angiopoietin-2表达明显下调(P<0.05)。结论抑制P130CAS基因表达可抑制食管癌ECA109细胞的增殖、迁移和侵袭,同时可下调Angiopoietin-2表达。 展开更多
关键词 食管肿瘤 P130CAS angiopoietin-2 慢病毒
下载PDF
基于BMP-2/BMP-7机制探讨生龙接骨胶囊预防老年骨质疏松性胸腰椎骨折术后再发性骨折的作用
14
作者 邓平征 周龙殿 +4 位作者 张斌 胡和军 邓雄伟 徐南云 江共涛 《中国当代医药》 CAS 2024年第12期4-8,共5页
目的探讨生龙接骨胶囊对老年骨质疏松性胸腰椎骨折(OTF)术后再发性骨折的作用,并基于骨形态发生蛋白-2/骨形态发生蛋白-7(BMP-2/BMP-7)机制初步分析其作用机制。方法选取2020年1月至2022年10月在南昌市洪都中医院收治的100例行经皮椎体... 目的探讨生龙接骨胶囊对老年骨质疏松性胸腰椎骨折(OTF)术后再发性骨折的作用,并基于骨形态发生蛋白-2/骨形态发生蛋白-7(BMP-2/BMP-7)机制初步分析其作用机制。方法选取2020年1月至2022年10月在南昌市洪都中医院收治的100例行经皮椎体成形术(PVP)的老年OTF患者为研究对象,按随机数字表法分为常规组(50例)和胶囊组(50例)。常规组采用常规的PVP治疗,胶囊组患者在常规组基础上服用生龙接骨胶囊治疗。比较两组患者椎体结构(Cobb角和伤椎椎体前缘高度比)、治疗前后血清BMP-2、BMP-7水平、骨代谢指标[骨特异性碱性磷酸酶(BALP)、Ⅰ型原胶原N端前肽(PⅠNP)、骨钙素(OST)]、骨密度(BMD)、康复情况[Oswestry腰椎功能障碍指数(ODI)]评估、疼痛等级[视觉模拟评分法(VAS)]评分、临床有效率、椎体再骨折发生率和不良反应发生情况。结果治疗后,两组患者Cobb角改善,伤椎椎体前缘高度比优于治疗前,胶囊组均优于常规组,差异有统计学意义(P<0.05);胶囊组的BMP-2、BMP-7表达量高于常规组,差异有统计学意义(P<0.05);患者术后再发性骨折情况均良好,胶囊组愈合速度快于常规组,差异有统计学意义(P<0.05);治疗后,胶囊组的BALP、PⅠNP、OST均高于常规组,差异有统计学意义(P<0.05);两组患者的BMD高于治疗前,且胶囊组高于常规组,ODI评分、VAS评分均低于治疗前,且胶囊组低于常规组,差异有统计学意义(P<0.05);胶囊组的临床总有效率(95.0%)高于常规组(80.0%),胶囊组的再骨折发生率(4%)低于常规组(18%),差异有统计学意义(P<0.05);两组患者均未见明显不良反应。结论生龙接骨胶囊能通过上调患者血清BMP-2、BMP-7水平,改善BMD从而预防老年OTF的术后再发性骨折,其机制可能与生龙接骨胶囊能刺激BMP信号通路,加速成骨细胞分化有关。 展开更多
关键词 骨折 生龙接骨胶囊 骨形态发生蛋白-2 骨形态发生蛋白-7 术后再发性骨折
下载PDF
手术标本YAP1、POU2F2、Cath-D表达与局限性肾癌术后复发的相关性及预测意义
15
作者 刘沛 韩广业 +1 位作者 张春锋 李振辉 《海南医学》 CAS 2024年第16期2339-2344,共6页
目的研究手术标本Yes相关蛋白1(YAP1)、POU2家族同源框2(POU2F2)和组织蛋白酶D(Cath-D)表达与局限性肾癌术后复发的相关性及预测意义。方法回顾性分析2019年1月至2022年3月新乡医学院第一附属医院收治的282例局限性肾癌手术患者的临床资... 目的研究手术标本Yes相关蛋白1(YAP1)、POU2家族同源框2(POU2F2)和组织蛋白酶D(Cath-D)表达与局限性肾癌术后复发的相关性及预测意义。方法回顾性分析2019年1月至2022年3月新乡医学院第一附属医院收治的282例局限性肾癌手术患者的临床资料,根据术后2年随访期内(2例失访)复发情况分为复发组42例和未复发组238例。比较两组患者的基线资料以及手术标本YAP1、POU2F2、Cath-D表达水平,采用多因素Logistic回归分析局限性肾癌术后复发的影响因素,采用受试者工作特征(ROC)曲线分析手术标本YAP1、POU2F2和Cath-D表达单一及联合预测局限性肾癌术后复发价值,采用Pearson相关分析法分析手术标本YAP1、POU2F2和Cath-D表达与复发时间的相关性。结果复发组患者的2017AJCCTNM分期T2期、Fuhrman分级Ⅳ级患者占比分别为80.95%、40.48%,明显高于未复发组患者的62.31%、21.85%,差异均有统计学意义(P<0.05);复发组患者的YAP1阳性率、POU2F2 mRNA和Cath-D阳性率分别为78.57%、1.70±0.36和83.33%,明显高于未复发组患者的47.90%、1.48±0.41、50.00%,差异均有统计学意义(P<0.05);校正前多因素Logistic回归分析结果显示,2017AJCCTNM分期T2期、Fuhrman分级>Ⅱ级、YAP1阳性、POU2F2mRNA、Cath-D阳性均与局限性肾癌术后复发相关(P<0.05),校正后YAP1阳性、POU2F2 mRNA和Cath-D阳性仍是局限性肾癌术后复发的独立相关危险因素(P<0.05);ROC分析结果显示,三者联合预测局限性肾癌术后复发的AUC为0.915,敏感度为80.95%,特异度为89.00%,明显高于各指标单独预测(P<0.05);Pearson相关性分析结果显示,手术标本YAP1、POU2F2、Cath-D表达与复发时间呈负相关(r=-0.802、-0.769、-0.834,P<0.05)。结论局限性肾癌患者手术标本YAP1、POU2F2和Cath-D表达水平与术后复发密切相关,其联合预测局限性肾癌术后复发具有良好参考价值。 展开更多
关键词 局限性肾癌 Yes相关蛋白1 POU2家族同源框2 组织蛋白酶D 术后复发 相关性
下载PDF
Factors associated with early recurrence after curative surgery for gastric cancer 被引量:39
16
作者 Wei-Ming Kang Qing-Bin Meng +2 位作者 Jian-Chun Yu Zhi-Qiang Ma Zhi-Tian Li 《World Journal of Gastroenterology》 SCIE CAS 2015年第19期5934-5940,共7页
AIM: To characterize patterns of gastric cancer recurrence and patient survival and to identify predictors of early recurrence after surgery.METHODS: Clinicopathological data for 417 consecutive patients who underwent... AIM: To characterize patterns of gastric cancer recurrence and patient survival and to identify predictors of early recurrence after surgery.METHODS: Clinicopathological data for 417 consecutive patients who underwent curative resection for gastric cancer were retrospectively analyzed. Tumor and node status was reclassified according to the 7th edition of the American Joint Committee on Cancer tumor-node-metastasis classification for carcinoma of the stomach. Survival data came from both the patients' follow-up records and telephone followups.Recurrent gastric cancer was diagnosed based on clinical imaging, gastroscopy with biopsy, and/or cytological examination of ascites, or intraoperative findings in patients who underwent reoperation.Predictors of early recurrence were compared in patients with pT1 and pT2-4a stage tumors. Pearson's χ 2 test and Fisher's exact test were used to compare differences between categorical variables. Survival curves were constructed using the Kaplan-Meier method and compared via the log-rank test. Variables identified as potentially important for early recurrence using univariate analysis were determined by multivariate logistic regression analysis.RESULTS: Of 417 gastric cancer patients, 80(19.2%)were diagnosed with early gastric cancer and the remaining 337(80.8%) were diagnosed with locally advanced gastric cancer. After a median follow-up period of 56 mo, 194 patients(46.5%) experiencedrecurrence. The mean time from curative surgery to recurrence in these 194 patients was 24 ± 18 mo(range, 1-84 mo). Additionally, of these 194 patients,129(66.5%) experienced recurrence within 2 years after surgery. There was no significant difference in recurrence patterns between early and late recurrence(P < 0.05 each). For pT1 stage gastric cancer, tumor size(P = 0.011) and pN stage(P = 0.048) were associated with early recurrence of gastric tumors.Patient age, pT stage, pN stage, Lauren histotype,lymphovascular invasion, intraoperative chemotherapy,and postoperative chemotherapy were independent predictors of early recurrence in patients with pT2-4a stage gastric cancer(P < 0.05 each).CONCLUSION: Age, pT stage, pN stage, Lauren histotype, lymphovascular invasion, intraoperative chemotherapy, and postoperative chemotherapy are independent factors influencing early recurrence of pT2-4a stage gastric cancer. 展开更多
关键词 STOMACH NEOPLASMS GASTRECTOMY D2lymphadenectomy recurrence CHEMOTHERAPY
下载PDF
Effect of ephrin-B2 on the expressions of angiopoietin-1 and-2 after focal cerebral ischemia/reperfusion 被引量:6
17
作者 Hui Xiao Qing Huang +2 位作者 Jia-qi Wang Qing-qing Deng Wen-ping Gu 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第11期1784-1789,共6页
Ephrin-B2 has been shown to participate in angiogenesis, but the underlying mechanisms involved remain unclear. In this study, a rat model of local cerebral ischemia was prepared by focal middle cerebral artery occlus... Ephrin-B2 has been shown to participate in angiogenesis, but the underlying mechanisms involved remain unclear. In this study, a rat model of local cerebral ischemia was prepared by focal middle cerebral artery occlusion, followed by 24-hour reperfusion. Then, ephrin-B2 protein was administered intracerebroventricularly for 3 consecutive days via a micro-osmotic pump. Western blot assay and quantitative real-time reverse transcription PCR demonstrated the expression levels of angiopoietin-1 (Ang-1) mRNA and protein in the penumbra cortex of the ephrin-B2 treated group were decreased at day 4 after reperfusion, and increased at day 28, while the expression levels of angiopoietin-2 (Ang-2) were highly up-regulated at all time points tested. Double immunofluorescent staining indicated that Ang-1 and Ang-2 were both expressed in vascular endothelial cells positive for CD31. These findings indicate that ephrin-B2 influences the expressions of Ang-1 and Ang-2 during angiogenesis following transient focal cerebral ischemia. 展开更多
关键词 nerve regeneration focal cerebral ischemia/reperfusion ephrin-B2 ANGIOGENESIS angiopoietin-1 angiopoietin-2 NEUROPROTECTION
下载PDF
Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models 被引量:5
18
作者 Nicha Wongjarupong Gabriela M Negron-Ocasio +17 位作者 Roongruedee Chaiteerakij Benyam D Addissie Essa A Mohamed Kristin C Mara William S Harmsen J Paul Theobald Brian E Peters Joseph G Balsanek Melissa M Ward Nasra H Giama Sudhakar K Venkatesh Denise M Harnois Michael R Charlton Hiroyuki Yamada Alicia Algeciras-Schimnich Melissa R Snyder Terry M Therneau Lewis R Roberts 《World Journal of Gastroenterology》 SCIE CAS 2018年第12期1321-1331,共11页
AIM To assess the performance of BALAD, BALAD-2 and their component biomarkers in predicting outcome of hepatocellular carcinoma(HCC) patients after liver transplant.METHODS BALAD score and BALAD-2 class are derived f... AIM To assess the performance of BALAD, BALAD-2 and their component biomarkers in predicting outcome of hepatocellular carcinoma(HCC) patients after liver transplant.METHODS BALAD score and BALAD-2 class are derived from bilirubin, albumin, alpha-fetoprotein(AFP), Lens culinaris agglutinin-reactive AFP(AFP-L3), and des-gammacarboxyprothrombin(DCP). Pre-transplant AFP, AFP-L3 and DCP were measured in 113 patients transplanted for HCC from 2000 to 2008. Hazard ratios(HR) for recurrence and death were calculated. Univariate and multivariate regression analyses were conducted. C-statistics were used to compare biomarker-based to predictive models. RESULTS During a median follow-up of 12.2 years, 38 patients recurred and 87 died. The HRs for recurrence in patients with elevated AFP, AFP-L3, and DCP defined by BALAD cut-off values were 2.42(1.18-5.00), 1.86(0.98-3.52), and 2.83(1.42-5.61), respectively. For BALAD, the HRs for recurrence and death per unit increased score were 1.48(1.15-1.91) and 1.59(1.28-1.97). For BALAD-2, the HRs for recurrence and death per unit increased class were 1.45(1.06-1.98) and 1.38(1.09-1.76). For recurrence prediction, the combination of three biomarkers had the highest c-statistic of 0.66 vs. 0.64, 0.61, 0.53, and 0.53 for BALAD, BALAD-2, Milan, and UCSF, respectively. Similarly, for death prediction, the combination of three biomarkers had the highest c-statistic of 0.66 vs 0.65,0.61, 0.52, and 0.50 for BALAD, BALAD-2, Milan, and UCSF. A new model combining biomarkers with tumor size at the time of transplant(S-LAD) demonstrated the highest predictive capability with c-statistics of 0.71 and 0.69 for recurrence and death. CONCLUSION BALAD and BALAD-2 are valid in transplant HCC patients, but less predictive than the three biomarkers in combination or the three biomarkers in combination with maximal tumor diameter(S-LAD). 展开更多
关键词 alpha-fetoprotein AFP-L3 des-gammacarboxyprothrombin BALAD BALAD-2 Hepatocellular carcinoma Liver TRANSPLANT recurrence Outcome
下载PDF
人Angiopoietin-2剪接体Ang_(2443)的快速克隆及高效表达
19
作者 蔡明清 张惠丽 +3 位作者 黄赞春 张宇 叶珏 惠汝太 《中国分子心脏病学杂志》 CAS 2003年第3期131-134,共4页
目的 构建Angiopoietin-2剪接体Ang_(2443)全长及功能结构域(CC区和FL区)的原核和真核表达质粒,并在大肠杆菌内获得高产量表达。方法 利用RT-PCR方法从人脐静脉内皮细胞中扩增获得Ang_(2443)功能结构域CC区和FL区,以剪接扩增PCR克隆全... 目的 构建Angiopoietin-2剪接体Ang_(2443)全长及功能结构域(CC区和FL区)的原核和真核表达质粒,并在大肠杆菌内获得高产量表达。方法 利用RT-PCR方法从人脐静脉内皮细胞中扩增获得Ang_(2443)功能结构域CC区和FL区,以剪接扩增PCR克隆全长片段,亚克隆至pET-32b(-)载体,IPTG诱导获得融合蛋白表达。凝血酶酶切后经柱层析纯化获得完全蛋白。结果 在所培养的人脐静脉内皮细胞中,Ang_(2443)是唯一表达的剪接体。以此构建了pET-CC、pET-FL和pET-Ang2三个原核和真核表达载体,并在大肠杆菌内获得高产量表达。1mM IPTG诱导表达后蛋白产量60%。凝血酶酶切完全,经柱层析纯化后获得完全蛋白。结论 成功克隆并表达了在所培养的人脐静脉内皮细胞中唯一表达的Angiopoietin-2剪接体Ang_(2443)全长及功能结构域蛋白。 展开更多
关键词 angiopoietin-2 剪接体 融合蛋白 凝血酶 血管发生
下载PDF
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C 被引量:5
20
作者 ángel Hernández-Bartolomé Rosario López-Rodríguez +5 位作者 María Jesús Borque Leticia González-Moreno Yolanda Real-Martínez Luisa García-Buey Ricardo Moreno-Otero Paloma Sanz-Cameno 《World Journal of Gastroenterology》 SCIE CAS 2016年第44期9744-9751,共8页
AIM To evaluate the efficacy of peripheral blood concentrations of angiopoietins(Ang) as cirrhosis biomarkers of chronic hepatitis C(CHC).METHODS Ang1 and Ang2 serum levels were measured by enzyme-linked immunosorbent... AIM To evaluate the efficacy of peripheral blood concentrations of angiopoietins(Ang) as cirrhosis biomarkers of chronic hepatitis C(CHC).METHODS Ang1 and Ang2 serum levels were measured by enzyme-linked immunosorbent assays(ELISA) in samples from 179 cirrhotic and non-cirrhotic CHC patients, classified according to the METAVIR system.Groups were compared by non-parametric MannWhitney U test. Subsequently, the association of peripheral concentrations of angiopoietins with the stage of fibrosis was analyzed using Spearman correlation test. Finally, the accuracy, sensitivity and specificity of circulating angiopoietins for cirrhosis diagnosis were determined by the study of the respective area under the curve of receiver operator characteristics(AUC-ROC).RESULTS Peripheral blood concentrations of Ang1 and Ang2 in CHC patients were significantly related to fibrosis. While Ang1 was decreased in cirrhotic subjects compared to non-cirrhotic(P < 0.0001), Ang2 was significantly increased as CHC progressed to the end stage of liver disease(P < 0.0001). Consequently, Ang2/Ang1 ratio was notably amplified and significantly correlated with fibrosis(P < 0.0001). Interestingly, the individual performance of each angiopoietin for the diagnosis of cirrhosis reached notable AUC-ROC values(above 0.7, both), but the Ang2/Ang1 ratio was much better(AUC-ROC = 0.810) and displayed outstanding values of sensitivity(71%), specificity(84%) and accuracy(82.1%) at the optimal cut-off(10.33). Furthermore, Ang2/Ang1 ratio improved the performance of many other previously described biomarkers or scores of liver cirrhosis in CHC.CONCLUSION Ang2/Ang1 ratio might constitute a useful tool for monitoring the progression of chronic liver disease towards cirrhosis and play an important role as therapeutic target. 展开更多
关键词 Chronic hepatitis C Area under the curve of receiver operator characteristics Liver fibrosis CIRRHOSIS angiopoietin-2 angiopoietin-1 BIOMARKER Angiogenesis
下载PDF
上一页 1 2 25 下一页 到第
使用帮助 返回顶部